RDRadNet RDNT · NASDAQ
$69.27 +0.68% (+$0.47)
- Market cap
- $5.45B
- Enterprise value
- $6.91B
- P/E
- -
- Forward P/E
- 140.0x
- PEG
- -
- P/S
- 2.4x
- P/FCF
- -
- EV/EBITDA
- 20.5x
- ROIC
- 1.4%
- Gross margin
- 9.7%
- Net margin
- -0.9%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 4.3x
- Beta
- 1.41
- Free float
- 89.5%
About the company
RadNet, Inc. (RDNT) is an American company specializing in providing diagnostic imaging services and outpatient healthcare. With an extensive network of radiology centers across the United States, RadNet is one of the leading providers of advanced diagnostic services for physicians and patients. The company focuses on providing a wide range of high-quality imaging examinations, including X-rays, magnetic resonance imaging (MRI), and computed tomography (CT), as well as innovative technologies that aid in timely and accurate disease diagnosis. RadNet, Inc. (RDNT) could be suitable for investors seeking opportunities in the healthcare sector with an emphasis on diagnostic services and advanced imaging technologies.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Howard G. Berger
Employees
9,060
Headquarters
Los Angeles
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number